$ Value
$0
Shares
301,667
Price
$0
Filed
May 9
Insider
Name
Stinchcomb Clinton Larry
Title
President and CEO
CIK
0001827441
Roles
Transaction Details
Transaction Date
2025-05-07
Code
M
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
603,333
Footnotes
On October 09, 2024 ("Grant Date"), the Company granted Clint Stinchcomb 905,000 restricted stock units ("RSUs") under the 2020 Omnibus Incentive Plan. Each RSU represents a contingent right to receive one share of common stock. On May 07, 2025, the Board and Compensation Committee determined that the Company met the ("First Performance Condition") of $4,500,000 in adjusted free cash flow and, as a result, one third 301,667 of these RSUs vested. The remaining two third 603,333 RSUs will vest upon the Company's achieving $9,000,000 in adjusted free cash flow ("Second Performance Condition") during the period October 1, 2024, to September 30, 2025 (Performance Period). In the event that the Second Condition is not met, the remaining two third of unvested RSUs will be cancelled. All vesting events are subject to continued employment on each applicable vesting date. | Represents the withholding of shares of the Company's common stock for tax purposes in connection with the vesting of restricted stock units previously granted.
Filing Info
Stinchcomb Clinton Larry's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-11 | CURI | M | — |
| 2026-03-11 | CURI | F | $643K |
| 2026-03-11 | CURI | M | — |
| 2025-11-25 | CURI | ▼ | $462K |
| 2025-11-24 | CURI | ▼ | $657K |
| 2025-11-21 | CURI | ▼ | $59K |
| 2025-11-20 | CURI | ▼ | $313K |
| 2025-11-11 | CURI | M | — |
| 2025-11-11 | CURI | F | $890K |
| 2025-11-11 | CURI | M | — |
Other Insiders at CURI (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| HUBERMAN JONATHAN | — | — | 2026-02-04 |
| HENDRICKS JOHN S | — | — | 2026-02-04 |
| Blank Matthew | — | — | 2026-02-04 |
| Nikzad Michael | — | — | 2026-02-04 |
|
Stinchcomb Clinton Larry
President and CEO
|
— | — | 2026-03-11 |
| Hendricks Elizabeth Ann | — | — | 2026-02-04 |
| Keeley Patrick J. | — | — | 2026-02-04 |
| Hendricks Andrew | — | — | 2026-02-04 |
|
Hayden Phillip Brady
Chief Financial Officer
|
— | — | 2026-02-10 |
|
Reed Rebecca R
Gen Counsel
|
— | — | 2026-02-10 |
|
Vilade John Thomas Jr
Chief Commercial Officer
|
— | — | 2026-02-10 |